{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T08:03:21Z","timestamp":1764230601518,"version":"3.46.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,26]]},"DOI":"10.7759\/cureus.97904","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T07:59:42Z","timestamp":1764230382000},"source":"Crossref","is-referenced-by-count":0,"title":["Conventional Salvage Chemotherapy Without Stem Cell Rescue for Relapsed or Refractory Extracranial Germ Cell Tumors: Insights From the Tertiary Cancer Center in a Developing Country"],"prefix":"10.7759","author":[{"given":"Tehreem","family":"Zahra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niaz","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urooj","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najma","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15225412","article-title":"Extracranial germ cell tumors in children: ten years of experience in three children's medical centers in Shanghai","volume":"15","author":"Jiang S","year":"2023","unstructured":"Jiang S, Dong K, Li K, et al.. Extracranial germ cell tumors in children: ten years of experience in three children's medical centers in Shanghai. Cancers. 2023, 15:5412. 10.3390\/cancers15225412","journal-title":"Cancers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.19.00190","article-title":"Germ cell tumors in adolescents and young adults","volume":"15","author":"Fonseca A","year":"2019","unstructured":"Fonseca A, Frazier AL, Shaikh F. Germ cell tumors in adolescents and young adults. J Oncol Pract. 2019, 15:433-41. 10.1200\/JOP.19.00190","journal-title":"J Oncol Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294976","article-title":"Diffusion-weighted imaging in pediatric extracranial germ cell tumors","volume":"18","author":"Cavalcante CE","year":"2023","unstructured":"Cavalcante CE, Magalh\u00e3es Pereira Souza F, Eiras Martins G, Milone Silva M, Pacheco Donato Macedo CR, Lederman H, Lopes LF. Diffusion-weighted imaging in pediatric extracranial germ cell tumors. PLoS One. 2023, 18:e0294976. 10.1371\/journal.pone.0294976","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143561","article-title":"Treatment and survival of malignant extracranial germ cell tumours in the paediatric population: a systematic review and meta-analysis","volume":"13","author":"Hulsker CC","year":"2021","unstructured":"Hulsker CC, El Mansori I, Fiocco M, et al.. Treatment and survival of malignant extracranial germ cell tumours in the paediatric population: a systematic review and meta-analysis. Cancers. 2021, 13:3561. 10.3390\/cancers13143561","journal-title":"Cancers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/20363613231216567","article-title":"Outcomes of pediatric extracranial germ cell tumors: a single center experience in a developing country","volume":"16","author":"Saliyeva S","year":"2024","unstructured":"Saliyeva S, Boranbayeva R, Bulegenova M, Zhumadullayev B, Nurzhanova G, Manzhuova L. Outcomes of pediatric extracranial germ cell tumors: a single center experience in a developing country. Rare Tumors. 2024, 16:10.1177\/20363613231216567","journal-title":"Rare Tumors"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2011.03.007","article-title":"A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors","volume":"25","author":"Voss MH","year":"2011","unstructured":"Voss MH, Feldman DR, Bosl GJ, Motzer RJ. A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors. Hematol Oncol Clin North Am. 2011, 25:557-76, viii -ix. 10.1016\/j.hoc.2011.03.007","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7272541","article-title":"Conventional-dose versus high-dose chemotherapy for relapsed germ cell tumors","volume":"2018","author":"McHugh DJ","year":"2018","unstructured":"McHugh DJ, Feldman DR. Conventional-dose versus high-dose chemotherapy for relapsed germ cell tumors. Adv Urol. 2018, 2018:7272541. 10.1155\/2018\/7272541","journal-title":"Adv Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10050972","article-title":"Overcoming chemotherapy resistance in germ cell tumors","volume":"10","author":"Orsz\u00e1ghov\u00e1 Z","year":"2022","unstructured":"Orsz\u00e1ghov\u00e1 Z, Kalavska K, Mego M, Chovanec M. Overcoming chemotherapy resistance in germ cell tumors. Biomedicines. 2022, 10:972. 10.3390\/biomedicines10050972","journal-title":"Biomedicines"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037213","article-title":"Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: a retrospective cohort study","volume":"103","author":"Ferhatoglu F","year":"2024","unstructured":"Ferhatoglu F, Paksoy N, Khanmammadov N, Yildiz A, Ahmed MA, G\u00fclbas Z, Basaran M. Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: a retrospective cohort study. Medicine. 2024, 103:e37213. 10.1097\/MD.0000000000037213","journal-title":"Medicine"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.102083","article-title":"High dose chemotherapy with autologous stem cell transplant for patients with advanced germ cell tumors: real-world evidence from a tertiary cancer center in Brazil","volume":"22","author":"Polho GB","year":"2024","unstructured":"Polho GB, Cunha MT, Coelho MH, et al.. High dose chemotherapy with autologous stem cell transplant for patients with advanced germ cell tumors: real-world evidence from a tertiary cancer center in Brazil. Clin Genitourin Cancer. 2024, 22:102083. 10.1016\/j.clgc.2024.102083","journal-title":"Clin Genitourin Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30179","article-title":"Outcomes of relapsed\/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: experience from a tertiary cancer center","volume":"70","author":"Ramanathan S","year":"2023","unstructured":"Ramanathan S, Prasad M, Vora T, et al.. Outcomes of relapsed\/refractory extracranial germ cell tumors treated on conventional salvage chemotherapy without stem cell rescue: experience from a tertiary cancer center. Pediatr Blood Cancer. 2023, 70:e30179. 10.1002\/pbc.30179","journal-title":"Pediatr Blood Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1437574","article-title":"High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed or refractory testicular cancer: a systematic review and meta-analysis","volume":"14","author":"Briones J","year":"2024","unstructured":"Briones J, Diaz P, Nicholson BD. High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed or refractory testicular cancer: a systematic review and meta-analysis. Front Oncol. 2024, 14:1437574. 10.3389\/fonc.2024.1437574","journal-title":"Front Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/08880018.2023.2187497","article-title":"High-dose chemotherapy with autologous stem cell transplantation for patients with extracranial germ cell tumors - experience of two Brazilian pediatric centers","volume":"40","author":"Villela NC","year":"2023","unstructured":"Villela NC, Seber A, Macedo CR, et al.. High-dose chemotherapy with autologous stem cell transplantation for patients with extracranial germ cell tumors - experience of two Brazilian pediatric centers. Pediatr Hematol Oncol. 2023, 40:539-53. 10.1080\/08880018.2023.2187497","journal-title":"Pediatr Hematol Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13216494","article-title":"Salvage treatment for extragonadal germ cell tumours: high-dose chemotherapy and autologous stem cell transplantation outcomes - a single-centre experience","volume":"13","author":"Topal A","year":"2024","unstructured":"Topal A, Erturk I, Koseoglu C, et al.. Salvage treatment for extragonadal germ cell tumours: high-dose chemotherapy and autologous stem cell transplantation outcomes - a single-centre experience. J Clin Med. 2024, 13:6494. 10.3390\/jcm13216494","journal-title":"J Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28125","article-title":"Salvage treatment for children with relapsed\/refractory germ cell tumors: the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience","volume":"67","author":"De Pasquale MD","year":"2020","unstructured":"De Pasquale MD, D'Angelo P, Crocoli A, et al.. Salvage treatment for children with relapsed\/refractory germ cell tumors: the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience. Pediatr Blood Cancer. 2020, 67:e28125. 10.1002\/pbc.28125","journal-title":"Pediatr Blood Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2025.26.7.2489","article-title":"Factors associated with survival in pediatric extracranial germ cell tumors: a study focusing on postoperative alpha-fetoprotein","volume":"26","author":"Tiyaamornwong S","year":"2025","unstructured":"Tiyaamornwong S, Vichitkunakorn P, Sripornsawan P, Choochuen P, Pongpanit C, Sirichamratsakul K, Sangkhathat S. Factors associated with survival in pediatric extracranial germ cell tumors: a study focusing on postoperative alpha-fetoprotein. Asian Pac J Cancer Prev. 2025, 26:2489-97. 10.31557\/APJCP.2025.26.7.2489","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10014-023-00460-x","article-title":"Impact of tumor markers on diagnosis, treatment and prognosis in CNS germ cell tumors: correlations with clinical practice and histopathology","volume":"40","author":"Takami H","year":"2023","unstructured":"Takami H, Graffeo CS, Perry A, et al.. Impact of tumor markers on diagnosis, treatment and prognosis in CNS germ cell tumors: correlations with clinical practice and histopathology. Brain Tumor Pathol. 2023, 40:124-32. 10.1007\/s10014-023-00460-x","journal-title":"Brain Tumor Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou Y","year":"2024","unstructured":"Zhou Y, Tao L, Qiu J, et al.. Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal Transduct Target Ther. 2024, 9:132. 10.1038\/s41392-024-01823-2","journal-title":"Signal Transduct Target Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13644","article-title":"Paclitaxel-ifosfamide-based therapy as salvage treatment in platinum-resistant recurrent\/metastatic head and neck cancer","volume":"38","author":"Chou MY","year":"2024","unstructured":"Chou MY, Wu WC, Chu PY, et al.. Paclitaxel-ifosfamide-based therapy as salvage treatment in platinum-resistant recurrent\/metastatic head and neck cancer. In Vivo. 2024, 38:1891-9. 10.21873\/invivo.13644","journal-title":"In Vivo"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14010131","article-title":"Efficacy and safety of three cycles of tip and sequential high dose chemotherapy in patients with testicular non-seminomatous germ cell tumors","volume":"14","author":"Aykan MB","year":"2024","unstructured":"Aykan MB, Yildiran Keskin G, Erturk \u0130, Acar R, Kose AF, Karadurmus N. Efficacy and safety of three cycles of tip and sequential high dose chemotherapy in patients with testicular non-seminomatous germ cell tumors. J Clin Med. 2024, 14:131. 10.3390\/jcm14010131","journal-title":"J Clin Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-022-03959-8","article-title":"First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment : A comprehensive review compiled by the German Testicular Cancer Study Group","volume":"40","author":"Pfister D","year":"2022","unstructured":"Pfister D, Oechsle K, Schmidt S, et al.. First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment : A comprehensive review compiled by the German Testicular Cancer Study Group. World J Urol. 2022, 40:2853-61. 10.1007\/s00345-022-03959-8","journal-title":"World J Urol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602724","article-title":"Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours","volume":"93","author":"De Giorgi U","year":"2005","unstructured":"De Giorgi U, Rosti G, Slavin S, et al.. Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours. Br J Cancer. 2005, 93:412-7. 10.1038\/sj.bjc.6602724","journal-title":"Br J Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.011411","article-title":"Salvage therapy for patients with germ cell tumor","volume":"12","author":"Rashdan S","year":"2016","unstructured":"Rashdan S, Einhorn LH. Salvage therapy for patients with germ cell tumor. J Oncol Pract. 2016, 12:437-43. 10.1200\/JOP.2016.011411","journal-title":"J Oncol Pract"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4274\/uob.galenos.2019.1284","article-title":"A retrospective study of patients with recurrent or refractory testicular germ cell tumors treated with high-dose chemotherapy and autologous peripheral-blood stem-cell transplantation single-center experience","volume":"18","author":"G\u00fcner SI","year":"2019","unstructured":"G\u00fcner SI, G\u00fcner E. A retrospective study of patients with recurrent or refractory testicular germ cell tumors treated with high-dose chemotherapy and autologous peripheral-blood stem-cell transplantation single-center experience. Bull Urooncol. 2019, 18:143-8. 10.4274\/uob.galenos.2019.1284","journal-title":"Bull Urooncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/413115-conventional-salvage-chemotherapy-without-stem-cell-rescue-for-relapsed-or-refractory-extracranial-germ-cell-tumors-insights-from-the-tertiary-cancer-center-in-a-developing-country","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T07:59:43Z","timestamp":1764230383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/413115-conventional-salvage-chemotherapy-without-stem-cell-rescue-for-relapsed-or-refractory-extracranial-germ-cell-tumors-insights-from-the-tertiary-cancer-center-in-a-developing-country"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.97904","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,26]]}}}